Dexcom Inc. put real money behind expanding its integration efforts, with a $75 million investment in the $200 million series D for Ōura Health Oy, the maker of the Ōura smart ring. Ōura and Dexcom ...

But 2024 was a relatively quiet year for smartwatches, during which iterative updates reigned supreme. That happens in a ...

Oura announced today that it completed a $200 million Series D funding round with investment from Dexcom (Nasdaq:DXCM).

The investment comes as part of a new health monitoring partnership between the continuous glucose monitor (CGM) maker and Oura, the maker of smart ring technology. Fidelity Management & Research Co.

Smart ring maker Oura announced on Thursday that it has closed a $200 million Series D funding round, bringing the company’s ...

Oura Ring 4 in six colors. ŌURA was founded in Finland in 2013—before Apple launched ... The latest funding round was led by ...

Dexcom’s OTC glucose biosensor Stelo is the first product to use the GenAI platform for improved weekly insights.

Oura’s series D round of funding included participation from Fidelity Management & Research company and glucose monitoring company Dexcom. The $200 million in funding brings Oura’s total valuation to ...

The $200 million Series D investment gives the smart ring maker a valuation of $5.2 billion. The past year has been an active one for Ōura. It acquired Sparta Science and Veri, launched its Gen 4 ring ...

The US FDA has issued a warning against the use of smartwatches or smart ring devices that claim to be able to measure blood glucose levels. The regulator points out that there are no approved ...

Finnish health tech firm Oura has closed a $200M Series D funding round that boosts its market valuation to $5.2B. The smart ...